Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Interaction Map Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 2675 to 2724 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor 3 subunit 1 (spliceosome associated protein 114) (sap 114) (sf3a120). [source:swissprot;acc:q15459]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 649\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5901.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5248.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12455\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor 3a subunit 2 (spliceosome associated protein 62) (sap 62) (sf3a66). [source:swissprot;acc:q15428]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 296\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5909.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4911.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.20306\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor 3a subunit 3 (spliceosome associated protein 61) (sap 61) (sf3a60). [source:swissprot;acc:q12874]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 648\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5901.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5248.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12455\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor 3b subunit 1 (spliceosome associated protein 155) (sap 155) (sf3b155) (pre-mrna splicing factor sf3b 155 kda subunit). [source:swissprot;acc:o75533]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 191\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5923.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4638.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.27712\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor 3b subunit 2 (spliceosome associated protein 145) (sap 145) (sf3b150) (pre-mrna splicing factor sf3b 145 kda subunit). [source:swissprot;acc:q13435]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 348\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5885.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4991.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.17914\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor 3b subunit 3 (spliceosome associated protein 130) (sap 130) (sf3b130) (pre-mrna splicing factor sf3b 130 kda subunit). [source:swissprot;acc:q15393]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 207\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5961.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4771.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.24946\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor 3b subunit 4 (spliceosome associated protein 49) (sap 49) (sf3b50) (pre-mrna splicing factor sf3b 49 kda subunit). [source:swissprot;acc:q15427]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1224\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4700.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4331.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08532\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor 4 isoform b; rna-binding protein. [source:refseq;acc:nm\_021164]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 395\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5269.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4532.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.16251\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor arginine/serine-rich 11 (arginine-rich 54 kda nuclear protein) (p54). [source:swissprot;acc:q05519]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1976\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6294.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5939.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05978\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor u2af 35 kda subunit (u2 auxiliary factor 35 kda subunit) (u2 snrnp auxiliary factor small subunit). [source:swissprot;acc:q01081]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1959\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5777.35\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5448.35\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06039\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent splicing factor u2af 65 kda subunit (u2 auxiliary factor 65 kda subunit) (u2 snrnp auxiliary factor large subunit) (hu2af(65)). [source:swissprot;acc:p26368]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1961\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor, arginine/serine-rich 1 (pre-mrna splicing factor sf2, p33 subunit) (alternative splicing factor asf-1). [source:swissprot;acc:q07955]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2549\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4824.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4725.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02087\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor, arginine/serine-rich 3 (pre-mrna splicing factor srp20) (x16 protein). [source:swissprot;acc:p23152]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 889\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6506.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5903.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10217\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor, arginine/serine-rich 8 (suppressor of white apricot protein homolog). [source:swissprot;acc:q12872]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2267\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 8743.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9146.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04599\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent splicing factor, proline-and glutamine-rich (polypyrimidine tract- binding protein-associated splicing factor) (ptb-associated splicing factor) (psf) (dna-binding p52/p100 complex, 100 kda subunit). [source:swissprot;acc:p23246]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2070\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 9638.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10178.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05607\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent sporulation-induced transcript 4-associated protein. [source:refseq;acc:nm\_018312]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1512\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7771.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7234.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07422\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent sprouty homolog 1 (spry-1) (fragment). [source:swissprot;acc:o43609]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 676\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6215.42\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5549.2\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.12006\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent sprouty homolog 2 (spry-2). [source:swissprot;acc:o43597]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 677\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent sprouty homolog 3 (spry-3). [source:swissprot;acc:o43610]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 675\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent sprouty homolog 4 (spry-4). [source:swissprot;acc:q9c004]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 674\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent spry domain-containing socs box protein ssb-1. [source:refseq;acc:nm\_025106]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2814\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent spry domain-containing socs box protein ssb-4. [source:refseq;acc:nm\_080862]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2806\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent squalene monooxygenase (ec 1.14.99.7) (squalene epoxidase) (se). [source:swissprot;acc:q14534]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2166\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7315.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6952.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05212\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent squamous cell carcinoma antigen 1 (scca-1) (protein t4-a). [source:swissprot;acc:p29508]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1694\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6165.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5767.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06904\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent squamous cell carcinoma antigen recognized by t cells 1; u4/u6.u5 tri-snrnp-associated 110 kda protein; ige autoantigen; sart1(259) protein; sart1(800) protein. [source:refseq;acc:nm\_005146]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 310\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5878.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4909.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.19736\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent sqv-7-like protein (fragment). [source:sptrembl;acc:o95454]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2222\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5066.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5309.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04793\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent sr rich protein. [source:refseq;acc:nm\_032870]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2257\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6534.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6245.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04626\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent ss18-like protein 1 (syt homolog-1). [source:swissprot;acc:o75177]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2766\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent ssxt protein (synovial sarcoma, translocated to x chromosome) (syt protein). [source:swissprot;acc:q15532]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2942\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent star-related lipid transfer protein 13 (stard13) (start domain- containing protein 13) (46h23.2). [source:swissprot;acc:q9y3m8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 478\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent star-related lipid transfer protein 4 (stard4) (start domain- containing protein 4). [source:swissprot;acc:q96dr4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1870\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6463.13\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6076.66\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0636\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent star-related lipid transfer protein 5 (stard5) (start domain- containing protein 5). [source:swissprot;acc:q9nsy2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1865\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6463.12\vspace{3pt}}&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent star-related lipid transfer protein 6 (stard6) (start domain- containing protein 6). [source:swissprot;acc:p59095]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1862\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6463.13\vspace{3pt}}&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent star-related lipid transfer protein 8 (stard8) (start domain- containing protein 8). [source:swissprot;acc:q92502]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 479\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent ste20-like kinase; ste2-like kinase. [source:refseq;acc:nm\_016281]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2980\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent stem cell growth factor; lymphocyte secreted c-type lectin; lymphocyte secreted c-type lectin. [source:refseq;acc:nm\_002975]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 486\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 12491.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10908.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14513\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent step ii splicing factor slu7. [source:refseq;acc:nm\_006425]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 661\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6254.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5575.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12191\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent sterile alpha and tir motif containing 1; sterile alpha and heat/armadillo motif protein, ortholog of drosophila. [source:refseq;acc:nm\_015077]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1621\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5911.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5520.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07094\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent steroid hormone receptor err1 (estrogen-related receptor, alpha) (err-alpha) (estrogen receptor-like 1). [source:swissprot;acc:p11474]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 905\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11256.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10230.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1003\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent steroid hormone receptor err2 (estrogen-related receptor, beta) (err-beta) (estrogen receptor-like 2) (err beta-2). [source:swissprot;acc:o95718]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 875\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11318.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10263.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10277\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent steroidogenic factor 1 (stf-1) (sf-1) (steroid hormone receptor ad4bp) (fushi tarazu factor homolog 1). [source:swissprot;acc:q13285]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2972\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent sterol regulatory element binding protein cleavage-activating protein (srebp cleavage-activating protein) (scap). [source:swissprot;acc:q12770]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 868\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6173.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5595.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10322\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent sterol regulatory element binding protein-1 (srebp-1) (sterol regulatory element-binding transcription factor 1). [source:swissprot;acc:p36956]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 712\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5944.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5317.78\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11781\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent sterol regulatory element binding protein-2 (srebp-2) (sterol regulatory element-binding transcription factor 2). [source:swissprot;acc:q12772]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 711\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent stip1 homology and u-box containing protein 1; serologically defined colon cancer antigen 7; carboxy terminus of hsp70p-interacting protein; heat shock protein a binding protein 2 (c-terminal). [source:refseq;acc:nm\_005861]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2350\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6765.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6480.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04406\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent stromal cell-derived factor 2 precursor (sdf-2). [source:swissprot;acc:q99470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1804\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5307.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 4980.54\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06571\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent stromal cell-derived factor 2-like protein 1 precursor (sdf2 like protein 1) (pwp1-interacting protein 8). [source:swissprot;acc:q9hcn8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1805\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent stromal interaction molecule 1 precursor. [source:swissprot;acc:q13586]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2607\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6476.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6380.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01498\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent stromal interaction molecule 2 precursor. [source:swissprot;acc:q9p246]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2614\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent structure-specific recognition protein 1 (ssrp1) (recombination signal sequence recognition protein) (t160) (chromatin-specific transcription elongation factor 80 kda subunit) (fact 80 kda subunit). [source:swissprot;acc:q08945]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 957\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4917.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4483.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09692\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/